STLN vs TOI
Starling Oncology, Inc. - Common Stock · The Oncology Institute, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | STLN | TOI |
|---|---|---|
| Price | $6.17 | $5.13 |
| Market Cap | $628.82M | $512.91M |
| P/E | — | — |
| P/B | — | — |
| P/S | 1.25 | 1.02 |
| ROE | — | — |
| Net Margin | -12.1% | -12.1% |
| Gross Margin | — | — |
| Revenue Growth | 27.8% | 27.8% |
| Dividend Yield | — | — |
| EPS | -$0.59 | -$0.61 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.